Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $471M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CDXS | CODEXIS INC | 1,345,000 | $42.06M | 8.9% | $3.62 | +807.3% | COM | 192005106 |
| OCUL | OCULAR THERAPEUTIX INC | 5,974,800 | $41.64M | 8.8% | $5.00 | +55.4% | COM | 67576A100 |
| — | CHIMERIX INC | 5,580,000 | $35.88M | 7.6% | $4.24 | — | COM | 16934W106 |
| CLDX | CELLDEX THERAPEUTICS INC | 844,000 | $32.61M | 6.9% | $4.43 | +883.3% | COM NEW | 15117B202 |
| HROW | HARROW HEALTH INC | 3,285,000 | $28.38M | 6.0% | $5.29 | +86.9% | COM | 415858109 |
| CYTK | CYTOKINETICS INC | 580,000 | $26.44M | 5.6% | $18.45 | +109.2% | COM NEW | 23282W605 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 724,400 | $20.58M | 4.4% | $21.12 | +16.8% | COM | 22663K107 |
| TARA | PROTARA THERAPEUTICS INC | 2,650,000 | $18M | 3.8% | $29.10 | -76.3% | COM STK | 74365U107 |
| SMLR | SEMLER SCIENTIFIC INC | 172,000 | $15.76M | 3.3% | $114.32 | -2.0% | COM | 81684M104 |
| STXS | STEREOTAXIS INC | 2,526,500 | $15.66M | 3.3% | $2.93 | +103.6% | COM NEW | 85916J409 |
| KROS | KEROS THERAPEUTICS INC | 265,750 | $15.55M | 3.3% | $52.08 | -4.2% | COM | 492327101 |
| — | KINIKSA PHARMACEUTICALS LTD | 1,025,000 | $12.06M | 2.6% | $15.94 | — | COM CL A | G5269C101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 342,000 | $11.7M | 2.5% | $23.39 | +35.1% | COM | 74366E102 |
| PRQR | PROQR THERAPEUTICS NV | 1,435,510 | $11.5M | 2.4% | $5.23 | +45.7% | SHS EURO | N71542109 |
| ETON | ETON PHARMACEUTICALS INC | 2,385,000 | $10.23M | 2.2% | $6.31 | -24.2% | COM | 29772L108 |
| — | SUTRO BIOPHARMA INC | 680,000 | $10.12M | 2.1% | $16.93 | — | COM | 869367102 |
| — | MERUS N.V. | 317,800 | $10.11M | 2.1% | $28.71 | — | COM | N5749R100 |
| LRMR | LARIMAR THERAPEUTICS INC | 883,602 | $9.534M | 2.0% | $11.37 | -2.2% | COM | 517125100 |
| — | FORTRESS BIOTECH INC | 3,750,000 | $9.375M | 2.0% | $2.69 | — | COM | 34960Q109 |
| — | REATA PHARMACEUTICALS INC | 330,000 | $8.702M | 1.8% | $26.37 | — | CLASS A | 75615P103 |
| — | TRACON PHARMACEUTICALS INC | 3,055,000 | $8.462M | 1.8% | $5.83 | — | COM NEW | 89237H209 |
| — | GINKGO BIOWORKS HOLDINGS INC | 929,780 | $7.726M | 1.6% | $8.31 | — | CLASS A SHARES | 37611X100 |
| PCVX | VAXCYTE INC | 315,800 | $7.513M | 1.6% | $38.73 | -40.0% | COM | 92243G108 |
| MGNX | MACROGENICS INC | 462,000 | $7.415M | 1.6% | $17.19 | +9.5% | COM | 556099109 |
| XOMA | XOMA CORP DEL | 338,350 | $7.055M | 1.5% | $10.28 | +127.5% | COM NEW | 98419J206 |
| TELA | TELA BIO INC | 449,867 | $5.758M | 1.2% | $13.29 | -4.7% | COM | 872381108 |
| HYPR | HYPERFINE INC | 763,075 | $5.523M | 1.2% | $9.78 | 0.0% | COM CL A | 44916K106 |
| BBIO | BRIDGEBIO PHARMA INC | 328,100 | $5.473M | 1.2% | $65.42 | -35.3% | COM | 10806X102 |
| — | NEOLEUKIN THERAPEUTICS INC | 1,047,300 | $5.048M | 1.1% | $5.58 | — | COM | 64049K104 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 229,000 | $5.024M | 1.1% | $24.51 | 0.0% | COM | 35104E100 |
| — | VERASTEM INC | 2,325,000 | $4.766M | 1.0% | $1.49 | — | COM | 92337C104 |
| — | SIERRA ONCOLOGY INC | 165,778 | $3.604M | 0.8% | $16.88 | — | COM NEW | 82640U404 |
| — | MEI PHARMA INC | 1,315,000 | $3.511M | 0.7% | $4.13 | — | COM NEW | 55279B202 |
| — | NUCANA PLC | 1,189,000 | $2.83M | 0.6% | $2.46 | — | SPONSORED ADR | 67022C106 |
| — | AVALO THERAPEUTICS INC | 1,459,400 | $2.481M | 0.5% | $2.18 | — | COM | 05338F108 |
| — | SYNLOGIC INC | 850,000 | $2.057M | 0.4% | $2.42 | — | COM | 87166L100 |
| — | AVEO BIOSCIENCES INC | 263,400 | $1.235M | 0.3% | $7.21 | — | COM NEW | 053588307 |
| LQDA | LIQUIDIA CORPORATION | 16,800 | $82,000 | 0.0% | $3.99 | 0.0% | COM NEW | 53635D202 |
| — | BIOLINERX LTD | 16,667 | $34,000 | 0.0% | $1.74 | — | SPONSORED ADS | 09071M205 |